MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 67 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,400 | +6300.0% | 17,777 | -91.6% | 0.00% | – |
| Q1 2023 | $100 | -16.7% | 211,927 | -11.5% | 0.00% | – |
| Q4 2022 | $120 | -99.6% | 239,401 | +714.0% | 0.00% | – |
| Q1 2021 | $31,000 | -94.8% | 29,409 | -93.3% | 0.00% | – |
| Q4 2020 | $597,000 | +1513.5% | 438,932 | +803.0% | 0.00% | – |
| Q3 2020 | $37,000 | -88.0% | 48,608 | -87.8% | 0.00% | – |
| Q2 2020 | $309,000 | -46.3% | 399,770 | -58.3% | 0.00% | -100.0% |
| Q1 2020 | $575,000 | +168.7% | 958,507 | +916.6% | 0.00% | – |
| Q4 2019 | $214,000 | -12.3% | 94,282 | -75.7% | 0.00% | – |
| Q3 2019 | $244,000 | -50.1% | 388,530 | -32.0% | 0.00% | -100.0% |
| Q2 2019 | $489,000 | -53.7% | 571,323 | -41.0% | 0.00% | -50.0% |
| Q1 2019 | $1,056,000 | +1430.4% | 968,908 | +1195.1% | 0.00% | – |
| Q3 2018 | $69,000 | -28.9% | 74,816 | -66.5% | 0.00% | – |
| Q2 2018 | $97,000 | +12.8% | 223,298 | +339.9% | 0.00% | – |
| Q2 2017 | $86,000 | -89.9% | 50,766 | -83.5% | 0.00% | -100.0% |
| Q1 2017 | $854,000 | – | 308,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
| Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
| IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
| Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
| Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
| BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
| Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |